PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Fifth Medical Center of Chinese, PLA General Hospital, Beijing, 100039, China.\', \'Fuyang Hospital of Anhui Medical University, Anhui, 236000, China.\', \'Fuyang Second People\'s Hospital, Anhui, 236000, China.\', \'Humanity and Health Clinical Trial Center, Humanity and Health Medical Group, Hong Kong SAR, China.\', \'The Fifth Medical Center of Chinese, PLA General Hospital, Beijing, 100039, China. chenzhuren264@126.com.\', \'The Fifth Medical Center of Chinese, PLA General Hospital, Beijing, 100039, China. qeq2004@sina.com.\', \'The Fifth Medical Center of Chinese, PLA General Hospital, Beijing, 100039, China. gkklau@hnhmgl.com.\', \'Humanity and Health Clinical Trial Center, Humanity and Health Medical Group, Hong Kong SAR, China. gkklau@hnhmgl.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12072-020-10058-6
?:doi
?:hasPublicationType
?:journal
  • Hepatology international
is ?:pmid of
?:pmid
?:pmid
  • 32734407
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.042
?:rankingScore_hIndex
  • 36
is ?:relation_isRelatedTo_publication of
?:title
  • Effect of COVID-19 on patients with compensated chronic liver diseases.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all